Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)
También te puede gustar
Ganadores
Últimas noticias cripto
Índice de Miedo y Avaricia de Criptomonedas Rebota a 28, Saliendo del Rango de "Miedo Extremo"
Los rendimientos de JGB suben mientras el mercado se centra en los datos económicos de esta semana
NewGen: Hasta el 28 de noviembre, ha comprado 13,000.23 SOL
Los mejores movimientos de ballenas Overview: "pension-usdt.eth" cortocircuitó BTC para convertirse en el oso más grande, "ZEC&MON Largest Bear" aumentó la posición corta de ETH
Anthropic está lanzando preparaciones de salida a bolsa y puede salir a bolsa ya en 2026
Atención al cliente:@weikecs
Cooperación comercial:@weikecs
Trading cuantitativo y MM:[email protected]
Servicios VIP:[email protected]